Open AccessTreatment of chronic hepatitis C among injecting drug users: A 5-year follow-up
Author(s) -
Maja Ružić,
Milotka Fabri,
Tomislav Preveden,
Katarina Kiralj,
Sandra Stefan Mikić,
Tatjana Vukadinov
Publication year - 2013
Publication title -
vojnosanitetski pregled
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.123
H-Index - 19
eISSN - 2406-0720
pISSN - 0042-8450
DOI - 10.2298/vsp110311050r
Subject(s) - medicine , ribavirin , genotype , hepatitis c , liver disease , genotyping , gastroenterology , liver biopsy , hepatitis , drug , interferon , hepatitis c virus , immunology , biopsy , virus , pharmacology , gene , biochemistry , chemistry
Hepatitic C infection (HCV) is a systemic, generalised disease with the prevalence of inflammation in the liver. The aim of this study was to determine the success of treatment for chronic hepatitis C with pegilated interferon alfa 2a and ribavirin in injecting drug users.